GlassScriptPrepare for your visit
H Lance Mandell
Hematology (Internal Medicine) · Nacogdoches, TX · NPI 1760432959
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,712.15
in general payments reported to CMS, 2019-2025 · $341 in 2025
The $341 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Who reported paying
General payments only, top 6 by amount.
- Celgene Corporation $4,348.46
- Pharmacyclics LLC, An Abbvie Company $377.13
- Myriad Genetic Laboratories, INC. $264.60
- Janssen Biotech, INC. $191.15
- Astrazeneca Pharmaceuticals LP $175.61
- Lilly USA, LLC $162.47
Drugs and devices associated with these payments
Imbruvica Monjuvi Myrisk Rytelo Xt Cdx Ultomiris Epkinly Enhertu Venclexta Zepzelca Verzenio Lenvima
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw H Mandell listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/170328/h-lance-mandell